CC122 - Chemical & Pharmaceuticals

CC122 is a novel agent for DLBCL. It is an orally available pleiotropic pathway modulator. It has antitumor and immunomodulatory activity. https://www.bocsci.com/cc122-cas-1015474-32-4-item-474963.html